Serum levels of growth hormone (GH)-dependent peptides could provide important and valuable measures of GH sensitivity and, potentially, responsiveness. In normal individuals, serum insulin-like growth factor I (IGF-I) concentrations are dependent on the dose of GH given, with IGF-I responsiveness not decreasing with age. Individuals heterozygous for the E180 GH receptor (GHR) splice mutation have normal IGF-I generation, but those homozygous for the E180 splice mutation have very low basal and stimulated IGF-I concentrations. Similar results are observed for the serum IGF-binding protein 3 (IGFBP-3) response to GH, with a correlation between changes in serum concentrations of IGF-I and changes in IGFBP-3 in normal, heterozygotic, GH-insensitive and GH-deficient participants. In individuals with the E180 splice mutation, IGF-I and IGFBP-3 tests show sensitivity and specificity for detecting GH insensitivity (GHI). In children with idiopathic short stature, it appears that some individuals have selective resistance to GH, with their ability to generate IGF-I more impaired than their ability to generate other GH-dependent peptides. This heterogeneous group may require individualization of GH dosage. IGF generation tests remain the best short-term, in vivo test for classic GHI, although diagnostic tests will undoubtedly require further modification to identify milder pathophysiologic abnormalities.

1.
Daughaday WH, Salmon WD, Alexander F: Sulfation factor activity of sera from patients with pituitary disorders. J Clin Endocrinol Metab 1959;19:743–748.
[PubMed]
2.
Kogut MD, Kaplan SA, Shimizu CS: Growth retardation: Use of sulfation factor as a bioassay for growth hormone. Pediatrics 1963;31:538–551.
[PubMed]
3.
Glick SM, Yalow RS, Berson SA: Immunoassay of growth hormone in plasma. Nature 1963;199:784–787.
[PubMed]
4.
Copeland KC, Underwood, LE, Van Wyk JJ: Induction of immunoreactive somatomedin C in human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. J Clin Endocrinol Metab 1980;50:690–697.
[PubMed]
5.
Kemp SF, Rosenfeld RG, Liu F, Gaspich S, Hintz RL: Acute somatomedin response to growth hormone: Radioreceptor assay versus radioimmunoassay. J Clin Endocrinol Metab 1981;52:616–621.
[PubMed]
6.
Rosenfeld RG, Kemp SF, Hintz RL: Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism and lack of correlation with growth rate. J Clin Endocrinol Metab 1981;53:611–617.
[PubMed]
7.
Van Vliet G, Styne DM, Kaplan SL, Grumbach MM: Growth hormone treatment for short stature. N Engl J Med 1983;309:1016–1022.
[PubMed]
8.
Plotnick LP, Van Meter QL, Kowarski AA: Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation. Pediatrics 1983;71:324–327.
[PubMed]
9.
Gertner JM, Genel M, Cianfredi SP, Hintz RL, Rosenfeld RG, Tamborlane WV, Wilson DM: Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr 1984;104:172–176.
[PubMed]
10.
Rudman D, Kutner MH, Blackston RD, Cushman RA, Bain RP, Patterson JH: Children with normal-variant short stature: treatment with human growth hormone for six months. N Engl J Med 1981;305:123–131.
[PubMed]
11.
Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J: Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994;15:369–390.
[PubMed]
12.
Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P: Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Acta Paediatr 1994;399(suppl):117–124.
13.
Attie KM, Carlsson LM, Rundle AC, Sherman BM: Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. J Pediatr 1995;127:244–250.
[PubMed]
14.
Rosenfeld RG: Broadening the growth hormone insensitivity syndrome. N Engl J Med 1995;333:1145–1146.
[PubMed]
15.
Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG: Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003;349:1139–1147.
[PubMed]
16.
Woods KA, Dastot F, Preece MA, Clark AJL, Postel-Vinay M-C, Chatelain P, Ranke MB, Rosenfeld RG, Amselem S, Savage MO: Phenotype: Genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997;82:3529–3535.
[PubMed]
17.
Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG: The IGF-I generation test revisited: A marker of GH sensitivity. J Clin Endocrinol Metab 2001;86:5176–5183.
[PubMed]
18.
Buckway CK, Selva KA, Pratt KL, Tjoeng E, Guevara-Aguirre J, Rosenfeld RG: Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity. J Clin Endocrinol Metab 2002;87:4754–4765.
[PubMed]
19.
Selva KA, Buckway CK, Sexton G, Pratt KL, Tjoeng E, Guevara-Aguirre J, Rosenfeld RG: Reproducibility of IGF generation tests with special reference to idiopathic short stature. Horm Res 2003;60:237–246.
[PubMed]
20.
Lieberman SA, Mitchell AM, Marcus R, Hintz RL, Hoffman AR: The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy. Horm Metab Res 1994;26:229–233.
[PubMed]
21.
Lissett CA, Shalet SM: The insulin-like growth factor-I generation test: Peripheral responsiveness to growth hormone is not decreased with ageing. Clin Endocrinol 2003;58:238–245.
[PubMed]
22.
Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LM: Mutations of the growth hormone receptor in children with idiopathic short stature. N Engl J Med 1995;333:1093–1098.
[PubMed]
23.
Rosenfeld RG: Broadening the growth hormone insensitivity syndrome. N Engl J Med 1995;333:1145–1146.
[PubMed]
24.
Salerno M, Balestrieri B, Matrecano E, Officioso A, Rosenfeld RG, Di Maio S, Fimiani G, Ursini MV, Pignata C: Abnormal GH receptor signaling in children with idiopathic short stature. J Clin Endocrinol Metab 2001;86:3882–3888.
[PubMed]
25.
Rosenfeld RG, Hwa V: Toward a molecular basis for idiopathic short stature. J Clin Endocrinol Metab 2004;89:1066–1067.
[PubMed]
26.
Jorge AA, Souza SC, Arnhold IJ, Mendonca BB: Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene. J Clin Endocrinol Metab 2002;87:469–472.
[PubMed]
You do not currently have access to this content.